Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 11,436 | 9,251 | 9,040 | 7,414 | 7,151 |
| Operating Income | -11,436 | -9,251 | -9,040 | -7,414 | -7,151 |
| Other Income | 499 | 559 | 617 | 696 | 804 |
| Pre-tax Income | -10,937 | -8,692 | -8,423 | -6,718 | -6,347 |
| Net Income Continuous | -10,937 | -8,692 | -8,423 | -6,718 | -6,347 |
| Net Income | $-10,937 | $-8,692 | $-8,423 | $-6,718 | $-6,347 |
| EPS Basic Total Ops | -1.19 | -1.05 | -1.05 | -0.75 | -0.64 |
| EPS Basic Continuous Ops | -1.27 | -1.01 | -0.98 | -0.78 | -0.75 |
| EPS Diluted Total Ops | -1.19 | -1.05 | -1.05 | -0.75 | -0.64 |
| EPS Diluted Continuous Ops | -1.27 | -1.01 | -0.98 | -0.78 | -0.75 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.05 | -1.05 | -0.75 | -0.75 |
| EBITDA(a) | $-11,432 | $-9,247 | $-9,036 | $-7,410 | $-7,147 |